| About us | Services | Products | News | Careers | Contact us |
|
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
Browse by category Anticaner agents in preclinical trials Anticancer molecular libraries
|
Browse products by category
Browse products by name 2-methoxyestradiol (angiogenesis inhibitor) 4-demethylpenclomedine(DMPEN) (alkylation agent) 4SC-202 (HDAC inhibitor) 4SC-203 (multi-target kinase inhibitor) 4SC-205 (human kinesin spindle protein Eg5 inhibitor) A-443654 (AKT inhibitor) A-674563 (AKT inhibitor) A-769662 (AMPK activator) ABC294640 (sphingosine kinase-2 inhibitor) Abexinostat(PCI-24781; CRA-024781) (HDAC inhibitor) ABI-008 (nab-docetaxel) ABI-009 (nab-rapamycin) ABI-101 (nab-17AAG) Abiraterone (androgen biosynthesis inhibitor) Abiraterone acetate (androgen biosynthesis inhibitor) ABR-215050 (Tasquinimod) (angiogenic inhibitor) ABT-199 (BCL inhibitor) ABT-263 (Novitoclax) (Bcl-2 Inhibitor) ABT-348 (receptor tyrosine kinase inhibitor) ABT-510 (angiogenesis inhibitor) ABT-518 (MMP inhibitor) ABT-737 (BCL-2 inhibitor) ABT-751 (Microtubule Inhibitor) ABT-767 (PARP inhibitor) ABT-806 (anti-EGFR monoclonal antibody ) ABT-828 (a biologic compound that blocks angiogenesis of cancer cells) AC480 (BMS-599626) (HER inhibitor) Acadesine (AMP-activated protein kinase activator) ACE-041 (an investigational protein therapeutic that inhibits angiogenesis) Acolbifene (selective estrogen receptor modulator) ACY-1215 (HDAC6 inhibitor) Acyline (MER104) (GnRH antagonist) AD-1001 (immunomodulatory therapy) Adenine Aderbasib (INCB007839) (sheddase inhibitor) ADI-PEG20 (arginine deiminase (ADI) formulated with polyethylene glycol) ADPM06 (PDT photosensitizer) ADW742 (NVP-ADW742) (IGF-IR inhibitor) AEE788 (EGFR, ErbB2, KDR, and Flt-1 inhibitor) AEG-40826 (HGS-1029) (IAP Inhibitor) AEG-41174 ( tyrosine kinase inhibitor) AEW-541 (NVP-AEW541) (IGF-IR inhibitor) AEZS-108 (AN-152) (LHRH-receptor specified doxorubicin conjugate) AEZS-112 (ZEN012) (tubulin inhibitor) AEZS-130 (EP-1572) (growth hormone agonist) AF802 (CH5424802) (ALK inhibitor) Afatinib (BIBW-2992 ) (EGFR inhibitor) Afimoxifene (selective estrogen receptor modulator) AFM-13 (a bispecific, tetravalent human antibody for Hodgkin Lymphoma.) AFP-464 (aryl hydrocarbon receptor agonist) AFX-2 (North American ginseng extract) AFX-9901 (anti-angiogenic agent) AG-1478 (EGFR inhibitor) AG-24322 (CDK inhibitor) AG-490 (EGFR and JAK inhibitor) AI-850 (cremaphor-free formulation of paclitaxel) AKR-501 (thrombopoietin receptor agonist) Alanosine (antimetabolic agent; adenylosuccinate synthetase inhibitor) ALB-109564 ( tubulin inhibitor; antimitotic agent) Alendronate sodium (geranyltranstransferase inhibitor) Alisertib (MLN-8237) (Aurora A kinase inhibitor) ALN-VSP (an RNAi therapeutic for the treatment of liver cancers ) ALT-801 (IL-2 recombinant fusion protein) Alvespimycin (Hsp90 inhibitor) Alvocidib (Flavopiridol) (CDK inhibitor) Ametantrone (DNA intercalator) AMG-208 (c-Met inhibitor) AMG-319 (PI3 Kinase inhibitor ) AMG-337 (c-Met inhibitor) AMG-386 (angiopoietin inhibitor, an anti-angiopoietin peptibody) AMG-780 (anti-angiopoietin antibody ) AMG-820 (antibody that targets c-fms and decreases tumor TAM function) AMG-888 (antibody that inhibits HER3 oncogenic signaling) AMG-900 (inhibitor of Aurora kinases A, B, and C.) Amonafide dihydrohloride (topoisomerase II inhibitor) Amonafide malate (AS-1413) (topoisomerase II inhibitor) AMP423 (cyanoaziridine-derivative) Amrubicin (anthracycline; DNA intercalactor; topoisomerase II inhibitor) Amsalog (topoisomerase II inhibitor) Amsilarotene (TAC-101) (oral synthetic retinoid) Amuvatinib (MP-470) (Multitargeted receptor tyrosine kinase inhibitor) AN-207 (LHRH doxorubicin conjugate) AN-2728 (PDE4 inhibitor) ANA-773 (TLR7 agonist) Anamorelin (RC1291) (ghrelin receptor agonist) Aneustat (OMN54) (mixture of extracts from three commonly used Chinese medicine components; Ganoderma lucidum, Salvia miltiorrhiza and Scutellaria barbata) Annamycin (DNA intercalactor; topoisomerase II inhibitor) ANX-510 (thymidylate synthase inhibitor) ANX-514 (docetaxel new formulation) AP-26113 (dual ALK and EGFR inhibitor) Apatinib (VEGFR inhibitor) Apaziquone (bioreductive prodrug, hypoxia toxic agent) APC-100 (androgen antagonist) APC-200 (ROS inhibitor) APC-300 (signal transduction inhibitor) APO-866 (FK866) (NAMPT inhibitor) Apricoxib (COX-2 inhibitor) AR-12 (OSU-03012) (PDK-1 inhibitor) AR-42 (HDAC inhibitor) Armodafinil (CNS stimulantor) ARN-509 (androgen receptor antagonist) Aroplatin (DNA crosslinking agent) ARQ-092 (AKT inhibitor) ARQ-501 ( R1668, beta-lapachone) (DNA damage checkpoint pathway activator) ARQ-621 (Eg5 inhibitor) ARQ-736 (BRAF Inhibitor) ARQ-761 (beta-lapachone prodrug; DNA damage checkpoint pathway activator) ARRY-380 (HER2 inhibitor) ARRY-520 (KSP inhibitor) ARRY-614 (p38 and Tie2 kinase inhibitor) Arzoxifene (selective estrogen receptor modulators (SERMs)) AS101 (interleukin-10 inhibitor) AS-605240 (PI3K Inhibitor) AS703026 (MSC1936369B) (MEK 1/2 inhibitor) AS703988 (MSC201510B) (MEK 1/2 inhibitor) ASP-3026 (ALK inhibitor) AT-101(Gossypol acetic acid) (Bcl-2 inhibitor) AT-13387 (Hsp90 inhibitor) AT-406 (IAP inhibitor) AT-7519 (CDK inhibitor) AT7867 (AKT inhibitor) AT-9283 (multiple kinase inhibitor) Ataluren (PTC124) (CFTR-G542X nonsense allele inhibitor) Atamestane (aromatase inhibitor) Atiprimod (STAT3 inhibitor) ATN-161 (integrin alpha5beta1 inhibitor) ATN-224 (SOD1 inhibitor) Atrasentan (ABT-627) (endothelin A receptor antagonist) AUY-922 (NVP-AUY922, VER-52296) (Hsp90 inhibitor) AVL-292 (BTK inhibitor) AVN-944 (VX-944) (IMPDH inhibitor) Axitinib (VEGFR inhibitor) AZD1152-HQPA (Aurora B inhibitor) AZD-1208 (pan-PIM kinase inhibitor) AZD-1480 (JAK2 inhibitor) AZD-2014 (mTOR inhibitor) AZD-2461 (PARP inhibitor) AZD-4547 (pan-FGFR inhibitor) AZD-4769 (EGFR tyrosine kinase inhibitor) AZD-4877 (KSP inhibitor) AZD-5363 (PKB/Akt inhibitor) AZD-5438 (CDK Inhibitor) AZD-6126 (tubulin Inhibitor) AZD-7451 ( TRK inhibitor) AZD-7762 (checkpoint kinase inhibitor) AZD-8055 (mTOR inhibitor) AZD-8931 (HER1and HER2 inhibitor) AZM-475271 (Src tyrosine kinase inhibitor) Bafetinib (INNO-406) (Bcr/Abl inhibitor) BAL101553 (microtubulin inhibitor) BAL27862 (microtubulin inhibitor) Banoxantrone (hypoxia toxic agent) Barasertib (AZD-1152) (Aurora B inhibitor) Bardoxolone methyl (RTA402) (antioxidant inflammation modulator) Batabulin sodium (tubulin inhibitor) Batimastat (MMP Inhibitor) BAY 10-00394 ( (CDK inhibitor) BAY 79-4620 (Antibody–drug conjugate) BAY 80-6946 (PI3K inhibitor) BAY 94-9392 (F18 tumor PET imaging agent) BBI-608 (Cancer cell stemness inhibitor) BC-819 (a plasmid comprised of the H19 gene regulatory sequences ) Becatecarin (DNA intercalator) Beclometasone dipropionate (potent glucocorticoid steroid) Belinostat (HDAC inhibitor) Belotecan (camptothecin derivative; topoisomerase I inhibitor) Bendamustine HCl (DNA alkylator) Beraprost (prostacyclin derivative) Berubicin (topoisomerase II inhibitor; anthracycline derivative) Betulinic acid ( ALS357) (melanoma-specific cytotoxic agent) Bevonium methylsulfate (also see CG-201) ( hCG inhibitor) BEZ235 ( NVP-BEZ235) (PI3K inhibitor) Bezielle (BZL-101) (extract of plant Scutellaria barbata; apoptosis inducer) BGC-945 (ONX-0801) (thymidylate synthase inhibitor) BGJ-398 (pan FGFR kinase inhibitor) BGT226 (NPV-BGT226) (PI3K inhibitor) BHQ-880 (Antibody) BI-2536 (Polo-like kinase 1 inhibitor) BI-505 (anti-ICAM-1 monoclonal antibody BI-505 ) BI-811283 (Aurora kinase inhibitor) BI-831266 (temporally not available) BI-836825 (temporally not available) BI-847325 (temporally not available) BI-853520 (focal adhesion kinase inhibitor) BIIB-015 (DM4-conjugated anti-Cripto monoclonal antibody ) BIIB-021 (CNF2024) (HSP90 inhibitor) BIIB-022 (a human, nonglycosylated IgG4 monoclonal antibody) BIIB028 (Hsp90 inhibitor) BIND-014 (PSMA-targeted docetaxel nanoparticles) BIW-8962 (anti-ganglioside GM2 monoclonal antibod) BIX02188 (MEK inhibitor) BIX-02188 (MEK5 inhibitor) BIX02189 (MEK inhibitor) BKM-120 (PI3K inhibitor) BMN-673 (PARP inhibitor) BMS-275183 (paciltaxel analogue, tubulin inhibitor) BMS-536924 (IGF-IR kinase inhibitor) BMS-641988 (androgen receptor (AR) antagonist) BMS-690514 (VEGFR inhibitor; HER inhibitor) BMS-754807 (IGF-1R inhibitor) BMS-777607 (Met tyrosine kinase inhibitor) BMS-794833 (Met and VEGFR inhibitor) BMS-863233 (XL-413) (CDC7 kinase inhibitor) BMS-906024 (NOTCH inhibitor) BMS-911543 (JAK2 inhibitor) BMS-936558 (an anti-programmed death-1 (MDX-1106)) BMS-936559 (an anti-programmed death-1) BNC-105 (Vascular disrupting agent, tubulin polymerization inhibitor) BNC105P (Vascular disrupting agent, tubulin polymerization inhibitor) Bosutinib (Abl and Src inhibitor) Brivanib (VEGFR2 inhibitor) Brivanib alaninate (VEGFR2 inhibitor) BT-062 (Anti-myeloma monoclonal antibody-DM4 immunoconjugate) BYL719 (PI3K inhbitor) C31510 (not available) Cabazitaxel (XRP-6258) (tubulin inhibitor) Cabozantinib ( XL-184) (VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor) CAL-101 (PI3K inhibitor) CALAA-01 (siRNA-based cancer drug) Calcitriol Capesaris (GTX-758) (estrogen receptor (ER) alpha agonist) Carboxyamidotriazole orotate (CTO) Carfilzomib (proteasome inhibitor) CB-1400 (Not Available) CC-1088 (selective cytokine inhibitory drug; phosphodiesterase-4 inhibitor) CC-115 (DNA-PK/TOR kinase inhibitor) CC-122 (Pleiotropic Pathway Modulator) CC-223(mTOR inhibitor) CCT128930 (AKT inhibitor) CCT-137690 (pan-Aurora kinase inhibitor) CDX-011 (antibody-drug conjugate). CDX-1401 (fusion protein / antibody ) Cediranib (AZD2171) (VEGF inhibitor) Celastrol (HSP90 inhibitor) CEP-11981 (VEGFR inhibitor) CEP-18770 (proteasome inhibitor) CEP-28122 (Anaplastic Lymphoma Kinase inhibitor) CEP-9722 (PARP inhibitor) Cevipabulin (antimicrotubule agent) CGS-21680 (adenosine A2A receptor agonist) CH5132799 (PI3K inhibitor) CH5424802 (ALK inhibitor) CHIR-265 (also see: RAF-265) CHR-2845 (HDAC inhibitor) CHR-3996 (HDAC inhibitor) Chrysophanic acid (EGFR/mTOR pathway inhibitor) CHS-828 (NAD inhibitor) Cipatinib (oral tyrosine kinase inhibitor) CKD-516 (microtubulin inhibitor) CKI27 (RG7304) (MEK inhibitor) CLT-008 (human myeloid progenitor cells) CNTO-95 (a fully human monoclonal IgG1 antibody) CO-101 (Gemcitabine elaidate; CP-4126) (antimetabolite agent) CO-1686 (AVL-301) (EGFR inhibitor) Cordycepin (also see: OVI-123) CP-547632 (VEGFR-2 inhibitor) CP-724714 (HER2 inhibitor) CPI-613 (metabolic inhibitor) CPX-1 (formulation of Irinotecan + Floxuridine) CPX-351 (formulation of cytarabine + daunorubicin) Crenolanib (CP-868596) (PDGFR inhibitor) Crizotinib (PF-2341066) (tyrosine kinase inhibitor) CRS-100 [a live-attenuated strain of Listeria monocytogenes (Lm)] CRS-207 [a weakened (attenuated) form of Listeria monocytogenes] CST-101 (the native NK-92 cell-line) CT-011 (a humanized monoclonal antibody (mAb) that modulates the immune response and inhibits tumor growth and the spread of metastases.) CUDC-101 (HDAC, EGFR and HER2 inhibitor) Custiren (TV-1001, OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] CV9103 (mRNA-derived prostate cancer vaccine) CVT-6883 (A2B adenosine antagonist) CWP232291 (Wnt signaling inhibitor) CX-5461 (RNA polymerase I Inhibitor) CYC-116 (Aurora kinase/VEGFR2 inhibitor) CYT-107 (Interleukin-7) CYT-387 (JAK inhibitor) CYT-6091 (a nanotherapeutic manufactured by covalently linking tumor necrosis factor-a (TNF) onto the surface of 30 nm particles of pegylated colloidal gold) Dabrafenib (GSK-2118436) (B-RAF inhibitor) Dacomitinib (PF-00299804) (EGFR inhibitor) Danusertib (PHA-739358) (Aurora kinase inhibitor) DCC-2036 (BCR-ABL inhibitor) Debio-0932 (CUDC-305) (Hsp90 inhibitor) Dinaciclib (SCH-727965, PS-095760) (CDK inhibitor) DMPEN(4-demethylpenclomedine) (alkylation agent) Doramapimod (p38 MAPK inhibitor) Dovitinib (TKI-258, CHIR258) (fibroblast growth factor receptor 3 (FGFR3) inhibitor) Droxinostat (HDAC inhibitor) DS-2248 DS-7423 (PI3K/mTOR kinase inhibitor) E-3810 (VEGFR/FGFR dual kinase inhibitor) E6201 ( MEK-1/MEKK-1 inhibitor) E7016 (PARP inhibitor) E7050 ( c-Met/VEGFR kinase inhibitor) E7272 (also see : ONTAK or denileukin diftitox) E7820 (angiogenesis inhibitor) EC-20 (tumor imaging agent) ECC-33 (RG7686) [monoclonal antibody] Edotecarin (PHA-782615; J-107088; ED-749) (topoisomerase inhibitor) Efaproxiral (radiosensitizer) EGEN-001 [non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12)] EGEN-002 [not available] Elacridar (P-glycoprotein inhibitor) Elacytarabine (antimetabolite agent) Elesclomol (HSP-90 Inhibitor) Elinafide (DNA intercalator) Elomotecan (BN-80927) (topoisomerase inhibitor) Elsamitrucin (DNA intercalator) Eltrombopag (thrombopoietin receptor agonist) EMD-1204831 (c-MET inhibitor) EMD-1214063 (c-Met inhibitor) Eniluracil (dihydropyrimidine dehydrogenase inhibitor) ENMD-1198 (antimitotic agent) ENMD-2076 (Aurora kinase inhibitor) Entinostat (MS-275, SNDX-275) (HDAC inhibitor) Enzastaurin (LY317615) (protein kinase C beta inhibitor) EP-100 [an LHRH receptor-targeting ligand
conjugated to a novel Epofolate (BMS-753493) (folate receptor-targeting antimitotic agent) Epothilone D ) (tubulin inhibitor) Eribulin mesylate (E7389) (tubulin inhibitor) Erismodegib (LDE225, NVP-LDE225) (Smo antagonist) Etalocib (LY293111) (LTB4 receptor antagonist) Ethinyl Estradiol Exatecan (topoisomerase inhibitor) Ezatiostat (glutathione S-transferase P1-1 (GSTP1-1) inhibitor) EZN-2208 (Pegylated SN-38) Fenretinide (RAR agonist) Foretinib (XL880, SK1363089, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor) Fosaprepitant (antiemetic agent) Fosbretabulin (combretastatinA-4phosphate, CA4P) (vascular disrupting agent) Fostamatinib (R788) (Syk kinase inhibitor) FT-1050 (Stem Cell Modulator) Ganetespib (STA-9090) (Hsp90 inhibitor) GANT58 (Hedgehog inhibitor) GDC-0032 (PI3K inhibitor) GDC-0068 (AKT inhibitor) GDC-0152 (IAP inhibitor, Smac mimetic) GDC-0425 (RG7602) (ChK-1 inhibitor) GDC-0623 (MEK inhibitor) GDC-0879 (B-Raf Inhibitor) GDC-0917 (IAP inhibitor) GDC-0941 (PI3K inhibitor) GDC-0973 (XL518) (MEK inhibitor) GDC-0980 (RG7422) ( PI3 kinase/mTOR inhibitor) GFB-204 (VEGFR and PDGFR inhibitor) GGTI-2418 (geranylgeranyltransferase I inhibitor) GI-4000 (Targeted Molecular Immunogen) GI-6207 (vaccine) Gimatecan (topoisomerase inhibtor) Ginsenosides Ro Givinostat (ITF2357) (HDAC inhibitor) GLPG0187 (integrin receptor antagonist) GO-203-2C (MUC1-targeted peptide) Gossypol (Bcl-2 inhibitor) GPX100 (anthracycline, DNA intercalator) GPX150 (anthracycline, DNA intercalator) GRN-1005 (ANG-1005) (paclitaxel conjugate, microtube inhibitor) GSK-1059615 (mTOR inhibitor) GSK-1292263 (GPR119 receptor agonist ) GSK-1904529a (IGF-1R Inhibitor) GSK-2110183 (AKT inhibitor) GSK-2126458 (PI3K inhibitor, mTOR inhibitor) GSK-2141795 (Akt inhibitor) GSK-2636771 (PI3K inhibitor) GSK-461364 (PLK Inhibitor) GSK-690693 (pan-Akt kinase inhibitor) Gusperimus (immunosuppressant agent) GW788388 (TGF-beta inhibitor) Halobetasol propionate Henatinib (multitargeted tyrosine kinase inhibitor) HM30181 (MDR1 inhibitor) HM30181 (MDR1 inhibitor) HM781-36B (irreversible pan-HER inhibitor) HMN-176 (PLK-1 inhibitor) HMN-214 (PLK-1 inhibitor) HSP-990 (HSP inhibitor) Hycanthone (Topoisomerase inhibitor, DNA intercalator) Hydroxytyrosol Iboctadekin (immunostimulatory cytokine ) Icotinib (EGFR inhibitor) Icotinib (EGFR inhibitor) Imexon (caspase inhibitor) IMGN-388 (Targeted Antibody Payload, TAP) IMGN-901 (lorvotuzumab mertansine) INC280 (INCB-028060) (c-MET inhibitor, RTK inhibitor) Indibulin (ZIO-301) (tubulin inhibitor) Indisulam (carbonic anhydrase inhbitor) Iniparib (BSI-201) (PARP inhibitor) INK-1117 (PI3K inhibitor) INK-128 (mTOR inhibitor) INNO-206 (DNA intercalating agent) Inolitazone (CS-7017, Efatutazone ) Ioflubenzamide I-131 (MIP-1145) IPH-2101 (human anti-NK-cell inhibitory receptor mAb) IPI-145 (INK-1197) (PI3K inhibitor) IPI-269609 (Hedgehog pathway inhibitor) IPI-926 (Hedgehog pathway inhibitor) Isatoribine (toll-like receptor 7 (TLR-7) agonist) ISF-35 (vaccine) Iso-Fludelone (microtubulin inhibitor) Istradefylline Ixazomib (MLN-9708) (the first oral proteasome inhibitor) JNJ-26481585 (HDAC inhibitor) JNJ-38877605 (tyrosine kinase inhibitor) JNS002 (Pegylated liposomal doxorubicin) JX-594 (thymidine kinase-deleted vaccinia-hGM-CSF) JX-929 (A highly tumor-selective vaccinia virus ) Karenitecin (Cositecan, BNP-1350). KB-004 (Humaneered™ monoclonal antibody) Ketamine KHK-2866 (Anti-HB-EGF Antibody) KP372-1 (Akt inhibitor) KRN7000 (RGI-2001) (immunomodulator) KRP-203 (Sphingosine-1-phosphate receptor agonist) KU-0063794 (mTOR inhibitor) KW-2478 (Hsp90 inhibitor) KX2-391 (rc kinase inhibitor) LDK-378 (ALK inhibitor) LE-DT (Liposome Encapsulated Docetaxel) Lemuteporfin (QLT-0074) (PDT photosensitizer) LEP-ETU (liposomal paclitaxel, PNU-93914) Levocetirizine lexibulin (CYT997) (Vascular disrupting agent) LGH447 LGK-974 LGX818 (Raf kinase inhibitor) Linifanib ( ABT869) (RTK inhibitor) Linsitnib (OSI-906) (IGF-1R inhibitor) Litronesib (aslo see: LY2523355) Lonafarnib (farnesyl transferase inhibitor) LOR-253 (MTF-1 inhibitor) LOR-500 (MELK inhibitor) Lucanthone (Topoisomerase inhibitor, DNA intercalator) Lurtotecan (OSI-221; NX221) (topoisomerase I inhibitor) LW6 (HIF-1α inhibitor) LY2090314 (GSK-3 inhibitor) LY2157299 (TGF-βR inhibitor) LY2181308 (antisense oligonucleotide) LY2228820 (p38MAPK inhibitor) LY2334737 (antimetabolite agent) LY2603618 (CHK2 inhibitor) LY2624587 (not available) LY2780301 (AKT inhibitor) LY2801653 (c-MET inhibitor) LY2874455 (FGFR inhibitor) LY2875358 (anti-c-MET monoclonal antibody) LY294002 (PI3K inhibitor) LY3007113 (p38 MAPK inhibitor) LY475776 (P-glycoprotein inhibitors) Marizomib (NPI-0052) (proteasome inhibitor) Masitinib (AB1010) (tyrosine kinase inhibitor) Masoprocol (NDGA) (lipoxygenase inhibitor) Maytansine (microtubule inhibitor) MDV3100 (selective androgen receptor modulator) ME-143 (NV-143) (NADH oxidase inhibitor) ME-344 (mTOR1/2 kinase inhibitor) MEK-162 (ARRY-162) (MEK1/2 inhibitor) Meprednisone Methoxyamine (TRC102) (DNA base excision repair (BER) inhibitor) Methyl aminolevulinate (PDT photosensitizer) MG-516 (multi-targeted kinase inhibitor) MGCD-265 (multitargeted tyrosine kinase inhibitor) Mifamurtide (L-MTP-PE. MTP-PE) (immunomodulatory agent) Milciclib (PHA-848125) (CDK inhibitor and TRKA inhibitor) Minoxidil MINT-1526A (An anti-murine integrin α5β1 antibody) MK-0429 (ανβ3 Integrin Inhibitor) MK-0731 (KSP inhibitor) MK-0752 (notch inhibitor) MK-1496 (Polo-like kinase 1 inhibitor) MK-1775 (WEE inhibitor) MK-2206 (Akt inhibitor) MK-2461 (Multitargeted Kinase Inhibitor) MK-4101 (not available) MK-4827 (PARP inhibitor) MK-5172 (protease inhibitor) MK-8033 (c-MET inhibitor) MK-8245 (a stearoyl-CoA desaturase (SCD) inhibitor) MKC1106-PP (immunotherapy) MLN-2238 (oral proteasome inhibitor, metabolite of MLN9708) MLN-2480 (Raf kinase inhibitor) MLN-8054 (aurora kinase inhibitor) MM-111 (a bispecific antibody) MM-151 (EGFR inhibitor) MM-302 (doxorubicin nanotherapy) MM-398 (irinotecan nanotherapy) Mocetinostat (MGCD-0103) (HDAC inhibitor) Motesanib (AMG-706) (tyrosine kinase inhibitor) Motexafin gadolinium (PDT photosensitizer, radiosensitizer) Motexafin lutetium (PDT photosensitizer, radiosensitizer) Moxifloxacin HCl MP-412 (AV-412) (EGFR/HER2 tyrosine kinase inhibitor) MPC-3100 (Hsp90 inhibitor) MT-110 (a Bispecific T cell Engager (BiTE)® antibody) Mubritinib (TAK-165) (EGFR inhibitor) Muparfostat (PI88, heparin sulfate) MVA-5T4 (attenuated modified Vaccinia Ankara virus) Neratinib (HKI272) (HER2 and EGFR inhibitor) Nilotinib (Bcr-Abl inhibitor) Nintedanib ( BIBF-1120) (VEGFR inhibitor) Nitroarginine (NG-nitro-L-arginine) (nitric oxide synthase inhibitor) NK-012 (SN-38-PEG conjugate, camptotecin conjugate) NKP-1339 (ruthenium-based transferrin targeting agent) NKP-2235 (gallium-based small molecule) NMS-1116354 (CDC7 kinase inhibitor) NMS-1286937 (PLK1 inhibitor) NOV-002 (chemoprotective agent) Novitoclax (ABT-263) (Bcl-2 Inhibitor) NS-018 (JAK2/Src inhibitor) NTX-10 (vaccine) NV-1020 (oncolytic herpes simplex virus type 1) NV-128 (mTOT inhibitor) NVP-AEW541 ( AEW541) NVP-BEP800 (BEP800) (Hsp90 inhibitor) Obatoclax ( GX15-070) (BCL-2 Inhibitor) Oblimersen (bcl-2 antisense oligodeoxynucleotide G3139) OBP-301 (Telomerase-Specific Replication-Competent Adenovirus) OCV-501 OCX-011 (Custiren, TV-1001) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] Odanacatib (MK-0822) (protease inhibitor) ODM-201 OGX-427 (Hsp27 antisense oligonucleotide ) Olaparib (AZD-2281) (PARP inhibitor) Omacetaxine mepesuccinate (Homoharringtonine) Omacetaxine mepesuccinate (Homoharringtonine) Ombrabulin (AVE8062) (tubulin inhibitor) ONX-0912 (proteasome inhibitor) ONX-0914 (immunoproteasome inhibitor) OPB-31121 (STAT3 inhibitor) OPB-51602 (STAT3 inhibitor) Orteronel (TAK-700) (steroid 17alpha-monooxygenase inhibitor) OSI-027 (mTOR inhibitor) OSI-420 (CP-473420) ( EGFR inhibitor ) OSI-7904L(also see: GS7904L, OVI-237 ) OSI-906 (Linsitnib) (IGF-1R inhibitor) Ozarelix (also see: SPI-153) P276-00 (DCK inhibitor) PA799 (PI3K class I inhibitor) Padeliporfin (WST11, Stakel) (PDT photosensitizer) Padoporfin (Tookad) (PDT photosensitizer) Palomid 529 (PI3K inhibitor; Akt inhibitor; mTOR inhibitor) Panobinostat (NVP-LBH589; LBH589) (HDAC inhibitor) Pasireotide (SOM-230) ( somatostatin receptor agonist) Pazopanib (GW786034) (tyrosine kinase inhibitor ) Pazopanib Hydrochloride (GW786034) PCI-27483 (factor VIIa inhibitor) PCI-32765 (BTK inhibitor) PD-0325901 (MEK inhibitor) PD-0332991 (CDK Inhibitor) PD098059 (MEK inhibitor; MAP kinase inhibitor) PD-153035 (EGFR inhibitor) Pelitinib (EKB569) (pan-ErbB tyrosine kinase inhibitor) Pelitrexol (GARFT inhibitor) (glycinamide ribonucleotide formyltransferase) Peramivir Perifosine (AKT Inhibitor) PF-03446962 (anti-ALK-1 monoclonal antibody) PF-03732010 (antibody drug, p-cadherin antagonist) PF-03758309 (PAK4 inhibitor) PF-04217903 ( MET tyrosine kinase inhibitor) PF-04554878 (FAK inhibitor) PF-04605412 (anti-A5B1 integrin monoclonal antibody ) PF-04691502 (PI3K/mTOR inhibitor) PF-04856884 (CVX-060) [the fusion of two Ang2 sequestering peptides] PF-0562271 (PF-562271; PF-00562271) (a FAK inhibitor) PF-3845 (a FAAH Inhibitor) PHA-665752 (c-MET inhibitor) Photochlor (PDT photosensitizer) PHT-427 (Akt inhibitor) PI-103 (PI3K inhibitor, and mTOR inhibitor) Picropodophyllin (AXL1717) (IGF-1 receptor inhibitor) PIK-75 (PI3K inhibitor) Pimavanserin Piroxantrone (topoisomerase II inhibitor) PLX-3397 (multitargeted tyrosine kinase inhibitor) PLX-4720 (B-Raf inhibitor) PNT-2258 (an oligonucleotide therapeutic encapsulated within a SMARTICLES formulation). PNU-93914 (liposomal paclitaxel, LEP-ETU) POL6326 (CXCR4 inhibitor) Polymyxin B sulphate Ponatinib (AP-24534) (tyrosine kinase inhibitor) PP242 (mTOR inhibitor) PP-242 (mTOR inhibitor) Pracinostat (SB939) (HDAC inhibitor) Pralatrexate (dihydrofolate reductase inhibitor) PRI-724 (CBP/beta-catenin antagonist; Wnt signaling pathway inhibitor) Prucalopride PRX-302 (protein drug) PTC-299 (VEGF inhibitor) Pterostilbene PTI-188 (a radiolabeled murine anti-melanin antibody) PU-H71 (Hsp90 inhibitor) PWT33597 (PI3K inhibitor) PX-478 (HIF-1alpha inhibitor) PX-866 (PI3K inhibitor) PZP115891 QBI-139 (protein drug) Quarfloxin (CX-3543) (G-quadruplex-interactive agent) Quinacrine (Mepacrine ; CBLC102) Quinagolide (D2 receptor agonist) Quizartinib (AC220) (FLT3 inhibitor) R1530 (Mitosis-angiogenesis inhibitor) R763 (AS703569) (Aurora kinase inhibitor) Ramelteon Ramoplanin RDEA-436 (MEK inhibitor) Refametinib (RDEA119; BAY86-9766) (MEK inhibitor) Regorafenib (BAY 73-4506) (oral multi-kinase inhibitor) Resiquimod (Toll-like receptor (TLR) agonist) Resminostat (4SC-201) (HDAC inhibitor) Resveratrol Retaspimycin (IPI504) (HSP90 inhibitor) Retigabine RG-7167 (MEK inhibitor) RG-7347 (MNRP1685, R7347, Anti-NRP1) RG7593 (anti-CD22-MCC-MMAE) RG7594 (antibody drug) RG7686 (ECC-33) [monoclonal antibody] Rigosertib(ON-01910 ) (PLK1 inhibitor) Rindopepimut (immunotherapy, vaccine) Riociguat RO4929097 (R4733) (gamma-secretase/Notch signalling pathway inhibitor) RO4987655 (MEK inhibitor) RO5045337 ( RG7112, R7112) (MDM2 (human homolog of double minutes-2; HDM2) antagonist) RO5126766 (Raf/MEK dual kinase inhibitor) RO518426 (V600E BRAF Blocker) RO5212054 (PLX3603, RG-7256) (BRAF(V600E) kinase inhibitor) RO5503781 (MDM2 antagonist) Roflumilast Rostaporfin (PDT photosensitizer) RRX-001 (radiosensitizer) Rucaparib (PF-01367338, AG-14699) (PARP1 inhibitor) Ruxolitinib (INC-424; INCB-18424) (JAK1 inhibitor) Ruxolitinib (JAK1 inhibitor) RX-0201 (Akt antisense oligonucleotide) Sabarubicin (DNA intercalator) SAR256212 (MM-121, human monoclonal antibody) SAR307746 (REGN901, anti-ANG2 monoclonal antibody) SAR411298 (FAAH inhibitor. Cancer pain) Saracatinib (AZD-0530) (Src and Abl inhibitor) Sarsasapogenin SB-1518 (JAK2 inhibitor) SB202580 (MEK inhibitor; MAP kinase inhibitor) SB-216763 (glycogen synthase kinase-3 (GSK-3) inhibitor) SB-431542 (TGF-beta receptor inhibitor, ALK inhibitor) SB-743921 (KSP inhibitor) SCH900776 (Chk1 inhibitor) Seliciclib (CDK inhibitor) Selumetinib (AZD-6244) (MEK 1/2 inhibitor) SGI-1776 (pan-Pim protein kinase inhibitor) SGN-75 (anti-CD70 monoclonal antibody) SGX-523 (Met Inhibitor) SHP-141 (HDAC inhibitor) Silatecan (AR-67; DB-67) (topoisomerase I inhibitor; camptotecin derivative) Silibinin ( extract of the milk thistle seeds; mixture of flavonolignans) Silmitasertib (CX-4945) (CK2 inhibitor) SJG-136 (BN2629, SG2000) (DNA replication inhibitor) SL-401 (human IL3 recombinantly conjugated to diphtheria toxin). SN-2310 (SN-38 conjugate with VE; topoisomerase I inhibitor) SNS-032 (BMS-387032) (CDK inhibitor) SNS-314 (Aurora kinase inhibitor) SNX-2112 (HSP90 inhibitor) Soblidotin (tubulin polymerization inhibitor) Sonoflora 1 ( SF1) (PDT photosensitizer) Sotatercept (ACE-011, human fusion protein ) Sotrastaurin (AEB071) (PCK inhibitor) SPI-1005 (ebselen-containing oral capsule) SR13668 (Akt inhibitor) SR-31747 (Peripheral sigma receptor antagonist) STA-1474 (Prodrug of ganetespib) (HSP90 inhibitor) Stannsoporfin (heme oxygenase inhibitor) Sulforaphane (natural antioxidant) SYM-004 (anti-EGFR monoclonal antibody mixture) SYP-0704A TAE684 (NVP-TAE684) (ALK Inhibitor) TAK-285 (HER2/EGFR dual kinase inhibitor) TAK-441 (Hedghog inhibitor) TAK-593 (VEGFR/PDGFR dual kinase inhibitor) TAK-701 (anti-HGF monoclonal antibody) TAK-733 (MEK inhibitor) TAK-901 (Aurora B kinase inhibitor ) TAK-960 (PLK1 inhibitor) Talampanel (AMPA-receptor antagonist) Talaporfin sodium (PDT photosensitizer) Taltobulin (tubulin inhibitor) Tamibarotene (retinoic acid receptor (RAR) alpha/beta agonist) Tandutinib (MLN0518) (tyrosine kinase inhibitor) Tanomastat (matrix metalloprotease inhibitor) Tarenflurbil ((NSAID drug, enantiomer of flurbiprofen) Tariquidar (p-glycoprotein inhibitor) TAS-108 (estrogenic receptor alpha (ERa) inhibitor) TAS-109 (DNA polymerase inhibitor) TAS266 (tetrameric Nanobody® agonist) Tasquinimod (ABR-215050) (angiogenic inhibitor) Teglarinad chloride (GMX-1777) Telaprevir (VX-950) Telatinib ( Tanespimycin) (Hsp90 inhibitor) Telcagepant Temoporfin (PDT photosensitizer) Terameprocol (transcriptional inhibitor) TG-0054 (CXCR4 antagonist) TG02 (multi-kinase inhibitor of CDKs, JAK2 and FLT3) TG100-115 (PI3K inhibitor) TG101348 ( JAK2 inhibitor) TGX-221 (PI3K inhibitor) TH-302 (hypoxia-activated prodrug) Ticagrelor Tipifarnib (farnesyl transferase inhibitor) Tirapazamine (hypoxia toic agent) Tivantinib (ARQ-197) (c-Met inhibitor) Tivozanib (AV-951) (VEGFR inhibitor) TL32711 (Smac mimetic) Toceranib (SU11654) (Hsp90 inhibitor) Tofacitinib (CP-690550) (JAK inhibitor) Tosedostat Tozasertib (MK-0457; VX-680) (Aurora inhibitor) Trametinib (GSK-1120212, JTP-74057) (MEK 1/2 inhibitor) TRC093 (a humanized IgG1 monoclonal antibody) TRC105 (human chimeric monoclonal antibody ) Tretazicar (DNA alkylating agent) Triapine (ribonucleotide reductase inhibitor) Triciribine (VQD-002) (Akt inhibitor) TRX-518 (fully humanized IgG1 anti-huGITR Mab) TST-88 (also see TST-10088, a recombinant protein prodrug based on a plant-derived toxin called ricin) Tubacin (HDAC6 inhibitor) Tubastatin-A (HDAC6 inhibitor) TV-1001 (Custiren, OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.] TXA127 (heptapeptide COX-2 inhibitor) U0126 (MEK inhibitor; MAP kinase inhibitor) U3-1565 (anti-HBEGF monoclonal antibody) Ursodeoxycholic acid ( Ursodiol) Ursodiol ( Ursodeoxycholic acid) V503 (human papillomavirus vaccine) V935 (hTERT vaccine) Vadimezan (AS-404; DMXAA) (vascular disrupting agent) Vandetanib (approved in 2011) Vandetanib (approved in 2011) (VEGFR and EGFR inhibitor) Vargatef Vatalanib (VEGFR inhibitor) Veliparib ( ABT-888) (PARP inhibitor) Vemurafenib (RG7204, PLX4032, RO5185426) (B-Raf inhibitor) Verteporfin (PDT photosensitizer) Virulizin (A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue). Vismodegib (RG3616, GDC-0449) (Hedgehog antagonist) Volasertib ( BI-6727) (Plk1 inhibitor) Voreloxin (SNS-595, Vosaroxin) Vosaroxin (Voreloxin, SNS-595) VP-701 (not available) VX-702 (p38 MAPK Inhibitor) VX-765 (Caspase inhibitor) WK-X-34 (P-glycoprotein inhibitors) WYE-354 (mTOR inhibitor) WZ4002 (EGFR inhibitor) Xen-2174 (conopeptide analog) XL019 (JAK2 Inhibitor) XL147 (SAR-245408) (PI3K inhibitor) XL647 (EGFR and ErbB2 inhibitor) XL765 (SAR-245409) (PI3K/mTOR inhibitor) XL888 (Hsp90 inhibitor) XL999 (Spectrum Selective Kinase Inhibitor) XR9051 (P-glycoprotein inhibitors) YM-155 (Survivin inhibitor) Zosuquidar (P-glycoprotein inhibitor) ZSTK474 (PI3K inhbitor) ZYC-300 (A plasmid DNA)
|
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
About us | Services | Products | News | Careers | Contact us